Scholars Central

Research articlePublished 20 Dec 2019

Acenocoumarol and Proton Pump Inhibitors Interaction: Results from a Prospective, Multicenter Study

Authors: Grau Bartomeu J, Gallardo Martínez LJ, Olona Tabueña N, Moreno Oliver A, Vallès Callol JA

1Department of Family Medicine, Raval Sud Primary Health Care Centre, Litoral de Barcelona, Catalan Health Institute, Spain; 2Department of Preventive Medicine and Public Health, Barcelona Primary Healthcare Evaluation, Quality and Information System Unit, Catalan Health Institute, Spain; 3University of Barcelona, Barcelona, Spain; 4Drug Support Unit, Barcelona Primary Health Care Area, Catalan Health Institute, Spain

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: The interaction between acenocoumarol and omeprazole is described to be possible in different forums even though the evidence shows that both can be prescribed together safely. Aim: To evaluate the introduction of omeprazole on the effect of acenocoumarol in primary care clinical practice. Design and setting: Cross-sectional study with prospective follow-up of the patients treated with acenocoumarol for 18 months period in 5 health urban areas. Method: Association of age, sex, anticoagulant dose, indication and INR values according the use of acenocoumarol and PPI. Results: Of the 260 patients with acenocoumarol (with 3,280 INR measurements) at the start, 126 (48.5%) had previously been with some PPI (97 took omeprazole, mean INR of 2.43), 134 patients were not taking any PPI at the start of the study. Of the patients not previously treated with a PPI, 52 started with some PPI during the monitoring period; in 47 cases the PPI was omeprazole, 33 (70.2%) of which had an INR within the therapeutic range just before the administration of omeprazole. After the administration of omeprazole, 30 patients (90.9%) remained within the therapeutic range. The mean INR values just before and after the administration of omeprazole were 2.47 and 2.46 respectively (P=0.814). Conclusion: The addition of omeprazole to patients treated with acenocoumarol did not modify the INR values, reaffirming that there is no drug interaction. Long-term concomitant treatment with acenocoumarol and omeprazole is compatible with the INR measures within the target range.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Community Medicine & Health Education
  • SubjectPublic Health & Epidemiology
  • SubjectEducation
  • BylineArticles whose byline prints “Grau Bartomeu J”
  • BylineArticles whose byline prints “Gallardo Martínez LJ”
  • BylineArticles whose byline prints “Olona Tabueña N”
  • BylineArticles whose byline prints “Moreno Oliver A”
  • BylineArticles whose byline prints “Vallès Callol JA”